Product correctly added to cart.

Standards and Solutions in Compliance with Pharmacopoeias
Standards and Solutions in Compliance with Pharmacopoeias

Standards and Solutions in Compliance with Pharmacopoeias

Standards and solutions in compliance with pharmacopoeias are essential reference materials used to ensure the quality, safety, and efficacy of pharmaceutical products. This category includes a wide range of solutions and reagents that adhere to the stringent requirements set forth by various pharmacopoeias, such as the European Pharmacopoeia (EP) and the British Pharmacopoeia (BP). These standards are critical for the calibration and validation of analytical methods, ensuring that pharmaceutical products meet regulatory standards. They support a broad spectrum of applications, including the analysis of active pharmaceutical ingredients (APIs), excipients, and finished drug products. By providing consistent and reliable reference points, these standards and solutions facilitate compliance with regulatory requirements, enhance quality control processes, and ensure the production of safe and effective pharmaceuticals. Their use is indispensable in pharmaceutical research, development, and manufacturing, ensuring that products adhere to the highest quality standards.

Read more

Products of "Standards and Solutions in Compliance with Pharmacopoeias"

Sort by


See more categories

This search does not contain any category.

products per page. 4391 products on this category.

BrandProduct dataPurityPrice rangeEstimated delivery
EDQM - European Pharmacopoeia logo
Sodium calcium edetate CRS
REF: 41-S0700000
CAS: 62-33-9
- - -115.00 €Wed 06 Nov 24
EDQM - European Pharmacopoeia logo
Flubendazole for system suitability CRS
REF: 41-Y0000139
CAS: 31430-15-6
- - -115.00 €Wed 06 Nov 24
British Pharmacopoeia logo
Fexofenadine impurity standard
REF: 47-1096
CAS:
- - -211.00 €Wed 06 Nov 24
EDQM - European Pharmacopoeia logo
Lisinopril dihydrate CRS
REF: 41-L0702000
CAS: 83915-83-7
- - -115.00 €Wed 06 Nov 24
EDQM - European Pharmacopoeia logo
Hexamidine diisetionate CRS
REF: 41-H0330000
CAS: 659-40-5
- - -115.00 €Wed 06 Nov 24
EDQM - European Pharmacopoeia logo
Iohexol impurity J CRS
REF: 41-I0320820
- - -115.00 €Wed 06 Nov 24
EDQM - European Pharmacopoeia logo
Dextranomer CRS
REF: 41-Y0000744
- - -115.00 €Wed 06 Nov 24
EDQM - European Pharmacopoeia logo
Second International Standard for Tobramycin
REF: 41-ISA_82_510
CAS: 32986-56-4
- - -115.00 €Wed 06 Nov 24
British Pharmacopoeia logo
Nabumetone
REF: 47-358
CAS: 42924-53-8
99.8%242.00 €Wed 06 Nov 24
British Pharmacopoeia logo
Phenylephrine hydrochloride
REF: 47-284
CAS: 61-76-7
100.0%242.00 €Wed 06 Nov 24
EDQM - European Pharmacopoeia logo
Nitric oxide - reference spectrum
REF: 41-N0930000
- - -115.00 €Wed 06 Nov 24
EDQM - European Pharmacopoeia logo
Tibolone CRS
REF: 41-Y0002348
CAS: 5630-53-5
- - -115.00 €Wed 06 Nov 24
EDQM - European Pharmacopoeia logo
Betaxolol impurity A CRS
REF: 41-B1103100
- - -115.00 €Wed 06 Nov 24
EDQM - European Pharmacopoeia logo
Cladribine CRS
REF: 41-Y0000639
CAS: 4291-63-8
- - -115.00 €Wed 06 Nov 24
British Pharmacopoeia logo
Valaciclovir impurity standard
REF: 47-1195
CAS:
- - -211.00 €Wed 06 Nov 24
British Pharmacopoeia logo
Ribavirin impurity standard
REF: 47-592
CAS:
- - -211.00 €Wed 06 Nov 24
EDQM - European Pharmacopoeia logo
Bufexamac impurity A CRS
REF: 41-Y0001729
CAS: 4547-57-3
- - -115.00 €Wed 06 Nov 24
British Pharmacopoeia logo
Salbutamol ketone impurity
REF: 47-704
CAS: 156547-62-5
- - -211.00 €Wed 06 Nov 24
EDQM - European Pharmacopoeia logo
Hyoscine CRS
REF: 41-Y0000483
CAS: 51-34-3
- - -115.00 €Wed 06 Nov 24
EDQM - European Pharmacopoeia logo
Diclofenac sodium CRS
REF: 41-S0765000
CAS: 15307-79-6
- - -115.00 €Wed 06 Nov 24
discount label

Sodium calcium edetate CRS


Ref: 41-S0700000

100mg115.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Flubendazole for system suitability CRS


Ref: 41-Y0000139

20mg115.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Ref: 47-1096

25mg211.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Lisinopril dihydrate CRS


Ref: 41-L0702000

50mg115.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Hexamidine diisetionate CRS


Ref: 41-H0330000

20mg115.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Ref: 41-I0320820

125mg115.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Ref: 41-Y0000744

50mg115.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Second International Standard for Tobramycin


Ref: 41-ISA_82_510

11.2mg115.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Nabumetone


Ref: 47-358

200mg242.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Phenylephrine hydrochloride


Ref: 47-284

100mg242.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Ref: 41-N0930000

1u115.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Ref: 41-Y0002348

160mg115.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Ref: 41-B1103100

10mg115.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Ref: 41-Y0000639

100mg115.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Ref: 47-1195

10mg211.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Ref: 47-592

50mg211.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Bufexamac impurity A CRS


Ref: 41-Y0001729

10mg115.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Ref: 47-704

25mg211.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Ref: 41-Y0000483

15mg115.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
discount label

Ref: 41-S0765000

80mg115.00 €
Estimated delivery in United States, on Wednesday 6 Nov 2024
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".